Prescient Therapeutics (ASX: PTX) advances innovative cancer therapies following successful FY 2021 (w/ Steven Yatomi-Clarke)

Small Caps - A podcast by Small Caps

Prescient Therapeutics (ASX: PTX) managing director and chief executive officer Steven Yatomi-Clarke joins Small Caps to discuss the...